First report of Nocardia fusca isolated in humans

Nocardia anaemiae sp. nov. isolated from an immunocompromised patient and the first isolation report of Nocardia vinacea from humans.

Two actinomycete strains that were isolated from patients in Japan were assigned provisionally to the genus Nocardia based on their morphological characteristics. The two isolates were further studied to determine their specific taxonomic status. Detailed chemotaxonomic characterization and 16S rDNA sequence data for the strains showed that they are most similar to Nocardia vinacea. DNA-DNA hyb...

First Report of the Isolation of Nocardia thailandica from the Bronchoalveolar Lavage of a Patient in Iran

Nocardiae are Gram-positive, filamentous, aerobic, relatively slow-growing, and weakly acid-fast bacteria which cause nocardiosis in humans. We describe a 53-year-old patient with chronic bronchitis referred to Al-Zahra Hospital, Isfahan. A bronchial washing sample was taken from the patient. A Nocardia-like microorganism was detected in microscopic evaluation. Based on the phenotypic and 16S r...

First Report on the Isolation of Nocardia Thailandica from the Bronchoalveolar Lavage sample of a Patient in Iran

First case report of pulmonary nocardiosis caused by Nocardia mexicana

INTRODUCTION Nocardia species usually cause opportunistic infections, and the frequency of these infections is increasing owing to the growing population of immunocompromised hosts. However, Nocardia species may sometimes cause an infection disease in immunocompetent hosts. Nocardia mexicana infections are the least common and are very rare. CASE PRESENTATION Herein, we report the first case ...

First report of a brain abscess caused by Nocardia veterana.

Among Nocardia species causing infections, Nocardia veterana is rarely isolated and is mostly described as causing pulmonary infections. This is the first presentation of a case of brain abscess attributable to an N. veterana infection in a patient with type 2 diabetes. Prolonged antibiotic therapy with trimethoprim-sulfamethoxazole led to successful clinical recovery.